Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost Of Revenue | 15,000 | 10,000 | 9,000 | 14,000 |
| Gross Profit | -15,000 | -10,000 | -9,000 | -14,000 |
| Selling General And Administration | 4.0M | 4.2M | 4.1M | 5.6M |
| General And Administrative Expense | 4.0M | 4.2M | 4.1M | 5.6M |
| Other Operating Expenses | 167,000 | 89,000 | 283,000 | 343,000 |
| Operating Expense | 4.2M | 4.3M | 4.3M | 5.9M |
| Operating Income | -4.2M | -4.3M | -4.3M | -5.9M |
| EBIT | -3.1M | -4.3M | -10.1M | -5.9M |
| Interest Expense | 1,000 | 2,000 | 4,000 | 104,000 |
| Interest Expense Non Operating | 1,000 | 2,000 | 4,000 | 104,000 |
| Interest Income | 828,000 | 800,000 | 467,000 | 219,000 |
| Interest Income Non Operating | 828,000 | 800,000 | 467,000 | 219,000 |
| Net Interest Income | 827,000 | 798,000 | 463,000 | 115,000 |
| Other Income Expense | 240,000 | -757,000 | -6.3M | -214,000 |
| Other Non Operating Income Expenses | 31,000 | 32,000 | 68,000 | 216,000 |
| Special Income Charges | 0.00 | -242,000 | -5.8M | 0.00 |
| Write Off | 0.00 | 133,000 | 0.00 | -- |
| Gain On Sale Of Security | 209,000 | -547,000 | -542,000 | -430,000 |
| Pretax Income | -3.1M | -4.3M | -10.1M | -6.0M |
| Tax Provision | -457,000 | 1.7M | 855,000 | 1.4M |
| Tax Effect Of Unusual Items | 30,360 | -315,600 | -1.7M | -113,950 |
| Net Income From Continuing And Discontinued Operation | -2.5M | -5.7M | -10.7M | -7.2M |
| Net Income From Continuing Operation Net Minority Interest | -2.5M | -5.7M | -10.7M | -7.2M |
| Net Income Including Noncontrolling Interests | -2.7M | -6.0M | -11.0M | -7.4M |
| Minority Interests | 147,000 | 332,000 | 280,000 | 235,000 |
| Net Income Common Stockholders | -2.5M | -5.7M | -10.7M | -7.2M |
| Net Income | -2.5M | -5.7M | -10.7M | -7.2M |
| EBITDA | -3.1M | -4.2M | -10.1M | -5.9M |
| Normalized EBITDA | -3.3M | -3.5M | -3.8M | -5.5M |
| Reconciled Depreciation | 15,000 | 10,000 | 9,000 | 14,000 |
| Basic EPS | -0.04 | -0.09 | -0.16 | -0.11 |
| Diluted EPS | -0.04 | -0.09 | -0.16 | -0.11 |
| Basic Average Shares | 68.0M | 67.4M | 67.4M | 66.7M |
| Diluted Average Shares | 68.0M | 67.4M | 67.4M | 66.7M |
| Total Unusual Items | 209,000 | -789,000 | -6.3M | -430,000 |
| Total Unusual Items Excluding Goodwill | 209,000 | -789,000 | -6.3M | -430,000 |
| Tax Rate For Calcs | 0.15 | 0.40 | 0.26 | 0.27 |
| Normalized Income | -2.7M | -5.2M | -6.0M | -6.8M |
| Diluted NI Availto Com Stockholders | -2.5M | -5.7M | -10.7M | -7.2M |
| Impairment Of Capital Assets | 0.00 | 109,000 | 5.8M | 0.00 |
| Net Income Continuous Operations | -2.7M | -6.0M | -11.0M | -7.4M |
| Net Non Operating Interest Income Expense | 827,000 | 798,000 | 463,000 | 115,000 |
| Other Gand A | 3.4M | 3.2M | 2.9M | 2.5M |
| Other Special Charges | -- | -- | -52,000 | -- |
| Reconciled Cost Of Revenue | 15,000 | 10,000 | 9,000 | 14,000 |
| Salaries And Wages | 634,000 | 959,000 | 1.1M | 3.1M |
| Total Expenses | 4.2M | 4.3M | 4.3M | 5.9M |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Cash And Cash Equivalents | 11.0M | 19.8M | 25.7M | 31.8M |
| Cash Cash Equivalents And Short Term Investments | 11.0M | 19.8M | 25.7M | 32.2M |
| Cash Financial | 11.0M | 19.8M | 25.7M | 31.8M |
| Other Short Term Investments | -- | -- | 0.00 | 336,000 |
| Receivables | 181,000 | 1.1M | 822,000 | 419,000 |
| Prepaid Assets | 336,000 | 696,000 | 551,000 | 397,000 |
| Current Assets | 11.5M | 21.6M | 27.0M | 33.0M |
| Gross PPE | 148.0M | 142.0M | 136.5M | 139.8M |
| Accumulated Depreciation | -138,000 | -123,000 | -113,000 | -104,000 |
| Net PPE | 147.9M | 141.9M | 136.4M | 139.7M |
| Goodwill And Other Intangible Assets | -- | -- | -- | 45.1M |
| Investments And Advances | 636,000 | 465,000 | 890,000 | 1.3M |
| Other Non Current Assets | 384,000 | 356,000 | 270,000 | 257,000 |
| Total Non Current Assets | 149.8M | 142.7M | 137.6M | 141.3M |
| Total Assets | 161.3M | 164.3M | 164.6M | 174.3M |
| Current Debt | -- | -- | -- | 700,000 |
| Current Debt And Capital Lease Obligation | -- | -- | -- | 700,000 |
| Accounts Payable | 2.1M | 1.8M | -- | -- |
| Payables | 2.1M | 1.8M | -- | -- |
| Payables And Accrued Expenses | 2.1M | 1.8M | 1.7M | 2.9M |
| Current Liabilities | 2.1M | 1.8M | 1.7M | 3.6M |
| Total Non Current Liabilities Net Minority Interest | 10.7M | 11.1M | 9.3M | 8.4M |
| Total Liabilities Net Minority Interest | 12.8M | 12.9M | 11.0M | 12.0M |
| Common Stock | 237.5M | 234.9M | 234.9M | 234.9M |
| Capital Stock | 237.5M | 234.9M | 234.9M | 234.9M |
| Retained Earnings | -120.3M | -117.7M | -112.0M | -102.8M |
| Gains Losses Not Affecting Retained Earnings | 29.0M | 31.8M | 28.1M | 28.4M |
| Common Stock Equity | 146.2M | 149.0M | 151.0M | 160.5M |
| Stockholders Equity | 146.2M | 149.0M | 151.0M | 160.5M |
| Total Equity Gross Minority Interest | 148.5M | 151.4M | 153.7M | 162.3M |
| Minority Interest | 2.4M | 2.4M | 2.7M | 1.8M |
| Total Capitalization | 146.2M | 149.0M | 151.0M | 160.5M |
| Net Tangible Assets | 146.2M | 149.0M | 151.0M | 160.5M |
| Tangible Book Value | 146.2M | 149.0M | 151.0M | 160.5M |
| Working Capital | 9.4M | 19.8M | 25.3M | 29.3M |
| Invested Capital | 146.2M | 149.0M | 151.0M | 161.2M |
| Total Debt | -- | -- | -- | 700,000 |
| Share Issued | 68.4M | 67.4M | 67.4M | 67.4M |
| Ordinary Shares Number | 68.4M | 67.4M | 67.4M | 67.4M |
| Capital Lease Obligations | -- | -- | -- | 0.00 |
| Current Capital Lease Obligation | -- | -- | -- | 0.00 |
| Current Notes Payable | -- | -- | 0.00 | 700,000 |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | 636,000 | 465,000 | -- | -- |
| Investmentin Financial Assets | 636,000 | 465,000 | -- | -- |
| Long Term Provisions | 371,000 | 344,000 | 258,000 | 245,000 |
| Non Current Accounts Receivable | 881,000 | -- | -- | -- |
| Non Current Deferred Assets | -- | -- | -- | 0.00 |
| Non Current Deferred Liabilities | 10.3M | 10.7M | 9.0M | 8.2M |
| Non Current Deferred Taxes Liabilities | 10.3M | 10.7M | 9.0M | 8.2M |
| Other Receivables | 181,000 | 175,000 | 822,000 | 419,000 |
| Taxes Receivable | -- | 882,000 | -- | -- |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Operating Cash Flow | -2.4M | -3.1M | -4.5M | -2.6M |
| Cash Flow From Continuing Operating Activities | -2.4M | -3.1M | -4.5M | -2.6M |
| Depreciation And Amortization | 15,000 | 10,000 | 9,000 | 14,000 |
| Depreciation Amortization Depletion | 15,000 | 10,000 | 9,000 | 14,000 |
| Stock Based Compensation | 634,000 | 959,000 | 1.1M | 3.1M |
| Deferred Tax | -457,000 | 1.7M | 855,000 | 1.4M |
| Deferred Income Tax | -457,000 | 1.7M | 855,000 | 1.4M |
| Change In Working Capital | 313,000 | -490,000 | -1.8M | 69,000 |
| Change In Receivables | -136,000 | -383,000 | -457,000 | -308,000 |
| Change In Payables And Accrued Expense | 449,000 | -107,000 | -1.3M | 377,000 |
| Other Non Cash Items | -- | -- | -12,000 | -153,000 |
| Capital Expenditure | -38,000 | -4,000 | -7,000 | -3.4M |
| Purchase Of PPE | -38,000 | -4,000 | -7,000 | 0.00 |
| Net PPE Purchase And Sale | -38,000 | 171,000 | -7,000 | 0.00 |
| Purchase Of Business | -- | -- | 0.00 | -36,000 |
| Purchase Of Investment | -206,000 | 0.00 | 0.00 | -969,000 |
| Sale Of Investment | 227,000 | 0.00 | 159,000 | 3.4M |
| Net Investment Purchase And Sale | 21,000 | 0.00 | 159,000 | 2.4M |
| Investing Cash Flow | -6.7M | -2.8M | -3.5M | -1.0M |
| Cash Flow From Continuing Investing Activities | -6.7M | -2.8M | -3.5M | -1.0M |
| Repayment Of Debt | -- | -- | 0.00 | -4,000 |
| Net Issuance Payments Of Debt | -- | -- | 0.00 | -4,000 |
| Issuance Of Capital Stock | -- | 0.00 | 1.5M | 0.00 |
| Net Common Stock Issuance | -- | 0.00 | 1.5M | 0.00 |
| Financing Cash Flow | 225,000 | 12,000 | 1.7M | 1.2M |
| Cash Flow From Continuing Financing Activities | 225,000 | 12,000 | 1.7M | 1.2M |
| Effect Of Exchange Rate Changes | -57,000 | 22,000 | 157,000 | -7,000 |
| Changes In Cash | -8.8M | -5.9M | -6.3M | -2.4M |
| Beginning Cash Position | 19.8M | 25.7M | 31.8M | 34.2M |
| End Cash Position | 11.0M | 19.8M | 25.7M | 31.8M |
| Free Cash Flow | -2.4M | -3.1M | -4.5M | -6.0M |
| Asset Impairment Charge | 25,000 | 242,000 | 5.8M | 0.00 |
| Capital Expenditure Reported | -- | -- | -4.0M | -3.4M |
| Common Stock Issuance | -- | 0.00 | 1.5M | 0.00 |
| Depreciation | 15,000 | 10,000 | 9,000 | 14,000 |
| Long Term Debt Payments | -- | -- | 0.00 | -4,000 |
| Net Business Purchase And Sale | -- | -- | 0.00 | -36,000 |
| Net Foreign Currency Exchange Gain Loss | 0.00 | 48,000 | 22,000 | 15,000 |
| Net Income From Continuing Operations | -2.7M | -6.0M | -11.0M | -7.4M |
| Net Long Term Debt Issuance | -- | -- | 0.00 | -4,000 |
| Net Other Investing Changes | -6.6M | -3.0M | -3.6M | -2,000 |
| Operating Gains Losses | -- | 48,000 | -30,000 | 15,000 |
| Proceeds From Stock Option Exercised | 225,000 | 12,000 | 225,000 | 1.2M |
| Sale Of PPE | 0.00 | 175,000 | -- | -- |
| Unrealized Gain Loss On Investment Securities | -192,000 | 425,000 | 520,000 | 394,000 |